Literature DB >> 31585047

Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair.

Dorothee Birkl1, Monique N O'Leary1, Miguel Quiros1, Veronica Azcutia1, Matthew Schaller1, Michelle Reed1, Hikaru Nishio2, Justin Keeney1, Andrew S Neish2, Nicholas W Lukacs1, Charles A Parkos1, Asma Nusrat1.   

Abstract

Mucosal wound repair is coordinated by dynamic crosstalk between endogenous and exogenous mediators and specific receptors on epithelial cells and infiltrating immune cells. One class of such receptor-ligand pairs involves formyl peptide receptors (FPRs) that have been shown to influence inflammatory response and repair. Here we explored the role of murine Fpr2/3, an ortholog of human FPR2/receptor for lipoxin A4 (ALX), in orchestrating intestinal mucosal repair. Compared with wild-type (WT) mice, Fpr2/3-/- mice exhibited delayed recovery from acute experimental colitis and perturbed repair after biopsy-induced colonic mucosal injury. Decreased numbers of infiltrating monocytes were observed in healing wounds from Fpr2/3-/- mice compared with WT animals. Bone marrow transplant experiments revealed that Fpr2/3-/- monocytes showed a competitive disadvantage when infiltrating colonic wounds. Moreover, Fpr2/3-/- monocytes were defective in chemotactic responses to the chemokine CC chemokine ligand (CCL)20, which is up-regulated during early phases of inflammation. Analysis of Fpr2/3-/- monocytes revealed altered expression of the CCL20 receptor CC chemokine receptor (CCR)6, suggesting that Fpr2/3 regulates CCL20-CCR6-mediated monocyte chemotaxis to sites of mucosal injury in the gut. These findings demonstrate an important contribution of Fpr2/3 in facilitating monocyte recruitment to sites of mucosal injury to influence wound repair.-Birkl, D., O'Leary, M. N., Quiros, M., Azcutia, V., Schaller, M., Reed, M., Nishio, H., Keeney, J., Neish, A. S., Lukacs, N. W., Parkos, C. A., Nusrat, A. Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair.

Entities:  

Keywords:  FPR2; GPCRs; epithelium; inflammation; inflammatory bowel disease

Mesh:

Substances:

Year:  2019        PMID: 31585047      PMCID: PMC6894067          DOI: 10.1096/fj.201901163R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  63 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

2.  Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42.

Authors:  Brian A Babbin; Algirdas J Jesaitis; Andrei I Ivanov; Daina Kelly; Mike Laukoetter; Porfirio Nava; Charles A Parkos; Asma Nusrat
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

3.  Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

Authors:  Marie Le Borgne; Nathalie Etchart; Anne Goubier; Sergio A Lira; Jean Claude Sirard; Nico van Rooijen; Christophe Caux; Smina Aït-Yahia; Alain Vicari; Dominique Kaiserlian; Bertrand Dubois
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

4.  Annexin A1 regulates intestinal mucosal injury, inflammation, and repair.

Authors:  Brian A Babbin; Mike G Laukoetter; Porfirio Nava; Stefan Koch; Winston Y Lee; Christopher T Capaldo; Eric Peatman; Eric A Severson; Roderick J Flower; Mauro Perretti; Charles A Parkos; Asma Nusrat
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC.

Authors:  M Baba; T Imai; M Nishimura; M Kakizaki; S Takagi; K Hieshima; H Nomiyama; O Yoshie
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

6.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

7.  Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.

Authors:  Andrew Menzies-Gow; Sun Ying; Ian Sabroe; Victoria L Stubbs; Dulce Soler; Timothy J Williams; A Barry Kay
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

8.  Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling.

Authors:  Miguel Quiros; Hikaru Nishio; Philipp A Neumann; Dorothee Siuda; Jennifer C Brazil; Veronica Azcutia; Roland Hilgarth; Monique N O'Leary; Vicky Garcia-Hernandez; Giovanna Leoni; Mingli Feng; Gabriela Bernal; Holly Williams; Priya H Dedhia; Christian Gerner-Smidt; Jason Spence; Charles A Parkos; Timothy L Denning; Asma Nusrat
Journal:  J Clin Invest       Date:  2017-08-07       Impact factor: 19.456

9.  Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation.

Authors:  Arne Giebeler; Konrad L Streetz; Oliver Soehnlein; Ulf Neumann; Ji Ming Wang; Lars-Ove Brandenburg
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 10.  Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.

Authors:  Christopher D Buckley; Derek W Gilroy; Charles N Serhan
Journal:  Immunity       Date:  2014-03-20       Impact factor: 31.745

View more
  11 in total

Review 1.  Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease.

Authors:  Wen-Sheng Yang; Jing-Lin Wang; Wei Wu; Guang-Fei Wang; Jun Yan; Qing Liu; Xiao-Yan Wu; Qing-Tong Zhou; De-Hua Yang; Ming-Wei Wang; Zhi-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2022-07-15       Impact factor: 7.169

Review 2.  Immune Cell Circuits in Mucosal Wound Healing: Clinical Implications.

Authors:  Sebastian Zundler; Verena Tauschek; Markus F Neurath
Journal:  Visc Med       Date:  2020-03-13

Review 3.  "Cell Membrane Theory of Senescence" and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications.

Authors:  Undurti N Das
Journal:  Biomolecules       Date:  2021-02-08

4.  Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage.

Authors:  Takuya Kuzumoto; Tetsuya Tanigawa; Akira Higashimori; Hiroyuki Kitamura; Yuji Nadatani; Koji Otani; Shusei Fukunaga; Shuhei Hosomi; Fumio Tanaka; Noriko Kamata; Yasuaki Nagami; Koichi Taira; Toshio Watanabe; Yasuhiro Fujiwara
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

Review 5.  Therapeutic potential of WKYMVm in diseases.

Authors:  Huan Ma; Xiaoming Guo; Zhiguo Wang; Mei Han; Hui Liu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

6.  Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing.

Authors:  Miguel Quiros; Darius Feier; Dorothee Birkl; Rachit Agarwal; Dennis W Zhou; Andrés J García; Charles A Parkos; Asma Nusrat
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-16       Impact factor: 12.779

Review 7.  Formyl peptide receptors in the mucosal immune system.

Authors:  Yu Sun Jeong; Yoe-Sik Bae
Journal:  Exp Mol Med       Date:  2020-10-20       Impact factor: 8.718

Review 8.  New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation.

Authors:  Miguel Camba-Gómez; Oreste Gualillo; Javier Conde-Aranda
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

9.  Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn's Disease.

Authors:  Marina de Paula-Silva; Gustavo Henrique Oliveira da Rocha; Milena Fronza Broering; Maria Luíza Queiroz; Silvana Sandri; Rodrigo Azevedo Loiola; Sonia Maria Oliani; Andrea Vieira; Mauro Perretti; Sandra Helena Poliselli Farsky
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

10.  Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer.

Authors:  Roberta De Matteis; Magdalena B Flak; Maria Gonzalez-Nunez; Shani Austin-Williams; Francesco Palmas; Romain A Colas; Jesmond Dalli
Journal:  Sci Adv       Date:  2022-02-02       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.